Financhill
Sell
48

RVMD Quote, Financials, Valuation and Earnings

Last price:
$97.76
Seasonality move :
0.33%
Day range:
$92.50 - $99.51
52-week range:
$29.17 - $124.49
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
11.84x
Volume:
10.2M
Avg. volume:
4.5M
1-year change:
138.55%
Market cap:
$18.9B
Revenue:
--
EPS (TTM):
-$5.18

Earnings Data

Next earnings date for RVMD
Feb 25
2026
Most recent earnings per share
-$1.61
Missed by $0.20
(Nov 5/2025)
Consensus Estimate
-$1.41
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RVMD Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 -- -- -- -$1.65 --
02/25/2026 Q4 $3.7M -- -- -$1.57 --
11/05/2025 Q3 $1.5M -- -$1.61 -$1.41 -$0.20
08/06/2025 Q2 $27.5M -- -$1.31 -$1.12 -$0.19
05/07/2025 Q1 -- -- -$1.13 -$1.06 -$0.08
02/26/2025 Q4 $346.2K -- -$1.12 -$0.96 -$0.16
11/06/2024 Q3 $346.2K -- -$0.94 -$0.88 -$0.06
08/07/2024 Q2 $807.7K -- -$0.81 -$0.76 -$0.04
05/08/2024 Q1 $674.2K -- -$0.70 -$0.72 $0.01
02/26/2024 Q4 $1.2M $742K -$1.14 -$0.88 -$0.27
11/06/2023 Q3 $857.1K -- -$0.99 -$1.00 $0.01
08/08/2023 Q2 -- $3.8M -$0.92 -- --
05/08/2023 Q1 -- $7M -$0.72 -- --
02/27/2023 Q4 -- $15.3M -$0.63 -- --
11/07/2022 Q3 -- $3.4M -$0.87 -- --
08/09/2022 Q2 -- $9.1M -$0.82 -- --
05/09/2022 Q1 -- $7.6M -$0.78 -- --
02/28/2022 Q4 -- $9.5M -$0.71 -- --
11/10/2021 Q3 -- $1.1M -$0.72 -- --
08/11/2021 Q2 -- $8.7M -$0.60 -- --
05/10/2021 Q1 -- $10.1M -$0.53 -- --
03/02/2021 Q4 -- $8.8M -$0.51 -- --
11/12/2020 Q3 -- $12.7M -$0.42 -- --
08/10/2020 Q2 -- $10M -$0.46 -- --
05/14/2020 Q1 -- $11.5M -$0.37 -- --
12/31/2019 Q4 -- $12.1M -$0.32 -- --
09/30/2019 Q3 -- $12.5M -$0.30 -- --
06/30/2019 Q2 -- $12.3M -$0.23 -- --
03/31/2019 Q1 -- $13.2M -$0.23 -- --
12/31/2018 Q4 -- $10.3M -$0.23 -- --

Revolution Medicines, Inc. Earnings Questions

  • How Much did Revolution Medicines, Inc. Generate in Revenue Last Quarter?

    Revolution Medicines, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Revolution Medicines, Inc. Beat Earnings Last Quarter?

    Revolution Medicines, Inc. announced earnings per share of -$1.61 which represents a miss of analyst forecast a -$1.41 per share.

  • Is Revolution Medicines, Inc. Profitable?

    Revolution Medicines, Inc. reported -$4.3M that represents -$0.02 per share over the last quarter.

  • What is the Analyst Consensus for Revolution Medicines, Inc. EPS Next Year?

    Revolution Medicines, Inc.'s earnings are forecast to decrease from -$3.58 per share to -$5.54 per share next year representing a decrease of -75.68%.

  • When is Revolution Medicines, Inc.'s Earnings Date?

    Revolution Medicines, Inc.'s next earnings date is February 25, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will ISRG Stock Be in 5 Years?
Where Will ISRG Stock Be in 5 Years?

Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…

Is Kratos Stock a Good Investment?
Is Kratos Stock a Good Investment?

UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…

Is Palantir Stock Going to Crash?
Is Palantir Stock Going to Crash?

AI and data analytics major Palantir (NASDAQ:PLTR) has become something…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Sell
50
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
73
BNAI alert for Jan 27

Brand Engagement Network, Inc. [BNAI] is down 25.55% over the past day.

Buy
52
CVLT alert for Jan 27

Commvault Systems, Inc. [CVLT] is down 31.94% over the past day.

Sell
48
RVMD alert for Jan 27

Revolution Medicines, Inc. [RVMD] is up 1.98% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock